Václav Šimánek

Dr. Václav Šimánek


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
VŠVáclav Šimánek
Václav Šimánek
LPLadislav Pecen
Ladislav Pecen
ZKZuzana Krátká
Zuzana Krátká
TFTomáš Fürst
Tomáš Fürst
HRHana Rezackova
Hana Rezackova
Radek KuceraRadek Kucera
Radek Kucera
There is an ongoing debate as to whether SARS-CoV-2 antibodies can be found in patients who have recovered from COVID-19 disease. Currently, there is no consensus on whether the antibodies, if present, are protective. Our regular measurements of SARS-CoV-2 antibodies, starting in July 2020, have provided us with the opportunity of becoming acquainted with the five different immunoassays. A total of 149 patients were enrolled in our study. We measured the samples using each immunoassay, then performing a virus neutralization test and comparing the results of SARS-CoV-2 antibodies with this test. We observed that the production of neutralizing antibodies is age-dependent. Elderly patients have a higher proportion of high neutralizing titers than young patients. Based on our results, and in combination with the literature findings, we can conclude that the serological SARS-CoV-2 antibody measurement is a helpful tool in the fight against COVID-19. The assays can provide information about the patient’s previous contact with the virus. Anti-spike protein assays correlate well with the virus neutralization test and can be used in the screening of potential convalescent plasma donors.

David SloukaDavid Slouka
David Slouka
ŠČŠtěpánka Čejková
Štěpánka Čejková
JHJana Hanáková
Jana Hanáková
PHPetr Hrabačka
Petr Hrabačka
SKStanislav Kormunda
Stanislav Kormunda
Radek KuceraRadek Kucera
Radek Kucera
Tonsillectomy is a routine surgery in otorhinolaryngology and the occurrence of postoperative bleeding is not a rare complication. The aim of this retrospective, observational, analytic, cohort study is to compare the incidence of this complication for the most common indications. A group of patients indicated for tonsillectomies for peritonsillar abscess (group I) was compared to a group of patients indicated for chronic and recurrent tonsillitis (group II). There are a lot of pathophysiological differences in patients indicated for acute tonsillectomy for peritonsillar abscess and in patients indicated for elective tonsillectomy for chronic or recurrent tonsillitis. No technique to minimize the risk of bleeding after tonsillectomy has been found and a large part of postoperative bleeding occurs in postoperative home-care, which makes this issue topical. In total, 2842 unilateral tonsillectomies from the years 2014–2019 were included in the study. Bleeding occurred in 10.03% and, surprisingly, despite completely different conditions in the field of surgery (oedema, acute inflammation in peritonsillar abscess), there was no statistically significant difference between incidence of postoperative bleeding in the studied groups (p = 0.9920). The highest incidence of bleeding was found in the patients of group I on the eighth postoperative day, with those aged 20–24 years (p = 0.0235) being the most at risk, and in group II, on the sixth postoperative day, with those aged 25–29 years (p = 0.0128) and 45–49 years (p = 0.0249) being the most at risk.

1 December 2005 in Transplantation Proceedings
Verified
Journal Article
Closed access
IDI. Dundová
I. Dundová
VTV. Treska
V. Treska
VŠVáclav Šimánek
Václav Šimánek
MMM. Michal
M. Michal

21 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
RVRadana Vrzáková
Radana Vrzáková
VŠVáclav Šimánek
Václav Šimánek
OTOndřej Topolčan
Ondřej Topolčan
VVVladimír Vurm
Vladimír Vurm
David SloukaDavid Slouka
David Slouka
Radek KuceraRadek Kucera
Radek Kucera
The anti-Müllerian hormone (AMH) is a glycoprotein that plays an important role in prenatal sex differentiation. It is used as a biomarker in polycystic ovary syndrome (PCOS) diagnostics, as well as for estimating an individual’s ovarian reserve and the ovarian response to hormonal stimulation during in vitro fertilization (IVF). The aim of this study was to test the stability of AMH during various preanalytical conditions that are in accordance with the ISBER (International Society for Biological and Environmental Repositories) protocol. Plasma and serum samples were taken from each of the 26 participants. The samples were then processed according to the ISBER protocol. AMH levels were measured in all the samples simultaneously using the chemiluminescent kit ACCESS AMH in a UniCel® DxI 800 Immunoassay System (Beckman Coulter, Brea, CA, USA). The study proved that AMH retains a relatively high degree of stability during repeated freezing and thawing in serum. AMH was shown to be less stable in plasma samples. Room temperature proved to be the least suitable condition for the storage of samples before performing the biomarker analysis. During the testing of storage stability at 5–7 °C, the values decreased over time for all the plasma samples but remained stable in the serum samples. We proved that AMH is highly stable under various stress conditions. The anti-Müllerian hormone retained the greatest stability in the serum samples.

1 May 2009
Verified
Journal Article
Closed access
JVJosef Vodička
Josef Vodička
VSV Spidlen
V Spidlen
JKJ Klecka
J Klecka
VŠVáclav Šimánek
Václav Šimánek
JSJ Safránek
J Safránek

1 March 2001
Verified
Journal Article
Closed access
PNP Neprasová
P Neprasová
VTV Treska
V Treska
VŠVáclav Šimánek
Václav Šimánek